Colorectal Cancer

What Does PD-L2 Tell Us About Advanced Colorectal Cancer?

December 30th 2020, 5:00pm


Results show the presence of PD-L2 in the tumor may be an independent predictor of survival outcomes for patients with advanced stage colon carcinoma.

Results Identify Sex-Specific Links Between Adiposity and CRC, but Much Still Unknown

December 30th 2020, 1:00pm


The connection between obesity and colorectal cancer is well established, but the mechanics are not understood.

NCI-Funded Study Finds Triple Therapy Packs a Punch in Metastic Colorectal Cancer

December 24th 2020, 12:00pm


Adding vemurafenib, known to target a mutation affecting 10% of metastatic colorectal cancers, made a big difference.

Study Probes Links Between Mutations, Metastasis in mCRC in China

December 23rd 2020, 2:47pm


Researchers sought to gain a better understanding of the relationship between genetic mutations in metastatic colon cancer (mCRC), advanced disease, and locations of primary tumors.

Guidance Describes Management of Malignant Colorectal Polyps

December 23rd 2020, 12:46am


Early detection of colon cancer is key to survival. New guidance advises endoscopists in identifying malignant colorectal polyps and recommendations for surgery.

Medicaid Expansion May Result in Earlier Colon Cancer Diagnosis, Study Says

December 13th 2020, 12:00am


The authors wrote that in states that expanded Medicaid health insurance coverage in 2014, there was an increase of early-stage colon cancer diagnoses compared with states that did not implement expansion.

AI Helps Determine Which Patients Benefit Most From Colorectal Cancer Treatment

December 9th 2020, 8:04pm


Researchers found the application of FOLFOXai, an artificial intelligence (AI)–based predictor of response to FOLFOX chemotherapy in metastatic colorectal cancer (mCRC), may lead to improved treatment outcomes for some patients with mCRC and other cancers.

Impact of Travel Distance on Quality Outcomes in Colorectal Cancer

November 12th 2020, 2:00pm


This study identified characteristics of patients with colorectal cancer who traveled farther for surgery and found that those who traveled tended to stay longer at the hospital.

Biomarker Use in Colorectal Cancer

December 18th 2019, 12:59am


Despite a 20% drop in mortality since 2009, colorectal cancer accounted for 9.8% (881,000) of deaths worldwide in 2018 and represents 10.2% of all cancer cases worldwide. It is No. 3 on the list of most prevalent cancers worldwide—1.8 million new cases in 2018—behind only lung cancer and breast cancer.

NGS Identifies Survival, Treatment Outcomes for Patients With CRC Genetic Mutations

April 7th 2019, 5:00pm


Genetic alternations in colorectal cancer (CRC) are linked to different survival and treatment outcomes, according to a study that used next-generation sequencing (NGS) of tumor DNA. The study was published in Journal of Clinical Oncology.